Literature DB >> 18031869

Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureus.

X L Liu1, Y J Xu, M L Go.   

Abstract

A library of chalcones with basic functionalities were evaluated for antibacterial activity against drug sensitive strains of Staphylococcus aureus and Escherichia coli. The most active compounds were 2-52 and 2-57 (MIC 6.3 microM S. aureus). These compounds had no activity against E. coli (MIC>100 microM). Both compounds were characterized by a ring A that was substituted with 2-hydroxy-4,6-dimethoxy-3-(1-methylpiperidin-4-yl) groups. The phenolic OH and 1-methylpiperidinyl groups were required for activity but the phenolic OH may play a more critical role. While the compounds were comparable to licochalcone A in terms of antibacterial activity, they caused less hemolysis of sheep erythrocytes at high concentrations (100 microM). It was noted that the structural requirements for limiting hemolytic activity were less stringent than those required for antibacterial activity. The present findings suggest that the chalcone framework is an attractive template for optimization to achieve better potency, lower toxicity and a wider spectrum of antibacterial activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18031869     DOI: 10.1016/j.ejmech.2007.10.007

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

Review 1.  A Comprehensive Review of Aminochalcones.

Authors:  Rimsha Irfan; Shikufa Mousavi; Meshari Alazmi; Rahman Shah Zaib Saleem
Journal:  Molecules       Date:  2020-11-17       Impact factor: 4.411

2.  (E)-1-(3,5-Difluoro-phen-yl)-3-(2,4-dimeth-oxy-phen-yl)prop-2-en-1-one.

Authors:  Tanxiao Huang; Dongdong Zhang; Quanzhi Yang; Xiaoyan Wei; Jianzhang Wu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-09-08

3.  (E)-1-(4-Meth-oxy-phen-yl)-3-(2,4,6-trimeth-oxy-phen-yl)prop-2-en-1-one.

Authors:  Yuepiao Cai; Zhankun Wang; Zhe Li; Meiling Zhang; Jianzhang Wu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-05-14

4.  (E)-3-(2,4-Dimeth-oxy-phen-yl)-1-(3,4-dimeth-oxy-phen-yl)prop-2-en-1-one.

Authors:  Xiaokai Wu; Xiaoqing Cai; Xianan Zheng; Zhennan Zhang; Xiaoqin Ye
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-31

5.  (E)-1-(Thio-phen-2-yl)-3-(2,4,6-tri-meth-oxy-phen-yl)prop-2-en-1-one.

Authors:  Hoong-Kun Fun; Thitipone Suwunwong; Teerasak Anantapong; Chatchanok Karalai; Suchada Chantrapromma
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-29

6.  Crystal structure of (E)-1-([1,1'-biphen-yl]-4-yl)-3-(3-nitro-phen-yl)prop-2-en-1-one.

Authors:  D Shanthi; T Vidhyasagar; K Rajeswari; M Kayalvizhi; G Vasuki; A Thiruvalluvar
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-17

7.  Synthesis and Preliminary Antimicrobial Analysis of Isatin-Ferrocene and Isatin-Ferrocenyl Chalcone Conjugates.

Authors:  Amandeep Singh; Grant Fong; Jenny Liu; Yun-Hsuan Wu; Kevin Chang; William Park; Jihwan Kim; Christina Tam; Luisa W Cheng; Kirkwood M Land; Vipan Kumar
Journal:  ACS Omega       Date:  2018-05-30

8.  Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.

Authors:  Hongfei Si; Chunyan Xu; Jili Zhang; Xukun Zhang; Bing Li; Xuzheng Zhou; Jiyu Zhang
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-03-01       Impact factor: 4.077

9.  (E)-1-(2-Amino-phen-yl)-3-(thio-phen-2-yl)prop-2-en-1-one.

Authors:  Suchada Chantrapromma; Pumsak Ruanwas; Nawong Boonnak; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-06-08

Review 10.  Phenolic Compounds Diminish Antibiotic Resistance of Staphylococcus Aureus Clinical Strains.

Authors:  Maria Miklasińska-Majdanik; Małgorzata Kępa; Robert D Wojtyczka; Danuta Idzik; Tomasz J Wąsik
Journal:  Int J Environ Res Public Health       Date:  2018-10-22       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.